Edmond Ryan received research grants from Pfizer for studies into inhaled insulin use as
treatment in general diabetes and from Novo Nordisk Canada for detemir insulin use in type …

We read the article by Nethery and colleagues1 with great interest, having noted a similar
dramatic increase in the incidence of gestational diabetes in Australia, coincident with …

Various challenge tests have been used around the world for the diagnosis of gestational
diabetes mellitus (GDM) 2, and substantial variation among these methods has been noted …

The past few years have seen significant controversy over the diagnosis and management
of gestational diabetes and its influence on perinatal outcomes. The debate over who to …

The benefit of identifying and treating all pregnant however, are specific for maternal
hyperglycaemia and all are influenced by maternal weight, age, and past and women with …

Gestational diabetes mellitus (GDM) 2 has been defined as any degree of glucose
intolerance with an onset or first recognition during pregnancy (1–3). Fetal complications of …

Gestational diabetes mellitus (GDM) complicates approximately 7% of pregnancies in the
USA. Despite recognition of the benefits of diagnosing and treating GDM, there are several …

Gestational diabetes mellitus is rapidly increasing in incidence, due to lifestyle changes,
increasing obesity and maternal age. This increase makes universal screening mandatory; …

Gestational diabetes is a heterogeneous disorder. Various metabolic etiologies underpin the
diagnosis and influence perinatal outcomes as well as an individual's propensity for the …

Financial Disclosure Dr. Damm has participated in a multinational study on the use of insulin
in pregnancy in collaboration with Novo Nordisk. No personal honorarium was received. Dr …